HS5409 Cytotoxic Spill Decontamination

(10:12)

Grier Leesa HS5409 3 default 1

(6:37)

What is the reference cytotoxic regimen in advanced gastric cancer?

(14:49)

Chemotherapy and Hazardous Drug Precautions

(4:9)

ECCO 15- ESMO 34, Berlin 2009: Guidelines for safer handling of cytotoxics

(3:49)

Hazardous Drug Spill

(1:50)

CIPO2015: Durable Immune Control of ALL Requires a Multi-Antigen Immune Response

(15:2)

2019 STAT115 Lect19.2 Cancer Immunotherapy Biomarkers

(17:42)

Hazardous Drug Spill Clean Up

(2:55)

Management on Chemotherapeutic Drug Spill

(1:43)

Genotoxicology.mp4

(32:45)

Immunotherapy

(30:16)

Immunotherapy: a new frontier in cancer treatment

(34:46)

HT1080 Cells HSP90 Inhibitor

(8)

Development of Biohybrid Multistage Nanovaccines for Melanoma

(10:33)

Harnessing Cytokines for Cancer Immunotherapy Symposium - Dr. Nathan West, Genentech

(30:)

Bispecific antibodies to engage Vγ9Vδ2-T cells for cancer immunotherapy

(30:36)

Lecture 5: How cytotoxic (CD8) Cells and helper T (CD4) cells are activated?

(16:28)

CIPO2015: Adoptive T Cell Immunotherapy Targeting the Minor Histocompatibility Antigen HA-1

(15:2)